Reading the tape
NASDAQ: PTCT
PTC Therapeutics, Inc.
Healthcare · Biotechnology
Market Cap
$5.43B
52w High
$87.50
52w Low
$35.95
P/E
7.74
Volume
1.20M
Outstanding Shares
82.91M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 61.11%Revenue (TTM): 114.51%FCF (TTM): 484.12%P/S: 18th pct
What changed
The stock rose 61.11% over the last year. Revenue grew 114.51% over the trailing twelve months. Operating margin moved from -37.5% to 49.5%. Free cash flow grew 484.12% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 18th percentile of their historical P/S range.
What would invalidate this read
Operating margin is at 49.5%. Revenue grew 114.51% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders.
CEOMatthew Klein
SectorHealthcare
IndustryBiotechnology
Employees939
IPO dateJun 20, 2013
Valuation
Forward P/E—
EV/EBITDA6.25
Enterprise value$5.55B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-22.75%
Gross margin90.96%▲3.20%vs FY2024
Operating margin49.5%▲231.96%vs FY2024
ROE-332.49%▼1104.96%vs FY2024
Analyst consensus
RatingBuy
Target price$89.67▲36.92%
15
Buy
9
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$0.44 · Revenue est $218.8M
View